Quoin Pharmaceuticals

(NASDAQ) QNRX

Current Price$3.25

Market Cap$8.65M

Since IPO (2021)-100%

5 Year-100%

1 Year-49%

1 Month-8%

Quoin Pharmaceuticals Financials at a Glance

Market Cap

$8.65M

Revenue (TTM)

$0.00

Net Income (TTM)

-$16.98M

EPS (TTM)

-$236.73

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$3.25

Volume

3,750,277

Open

$4.20

Price

$3.25

Volume

3,750,277

Open

$4.20

Previous Close

$3.25

Daily Range

$3.25 - $5.07

52-Week Range

$3.25 - $41.80

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$3.25

Volume

3,750,277

Open

$4.20

Previous Close

$3.25

Daily Range

$3.25 - $5.07

52-Week Range

$3.25 - $41.80

Estimated Earnings Date

Aug 6, 2026

QNRX News

Quoin (QNRX) Q2 Loss Beats Estimates

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quoin Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Michael Myers, PhD

Website

www.quoinpharma.com

Headquarters

Ashburn, VA 20148-7349, US

QNRX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-292.33%

Return on Capital

-124.17%

Return on Assets

-108.18%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.65M

Shares Outstanding

1.96M

Volume

3.75M

Avg. Volume

99.68K

Financials (TTM)

Gross Profit

-$24.93K

Operating Income

-$17.45M

EBITDA

-$16.88M

Operating Cash Flow

-$15.86M

Capital Expenditure

$4.00

Free Cash Flow

-$15.86M

Cash & ST Invst.

$3.12M

Total Debt

$0.00

Quoin Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$24.93K

N/A

Gross Margin

0.00%

N/A

Market Cap

$8.65M

N/A

Market Cap/Employee

$2.88M

N/A

Employees

N/A

Net Income

-$4.98M

-30.7%

EBITDA

-$4.96M

-30.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.12M

-73.0%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.08%

N/A

Return on Invested Capital

-1.69%

N/A

Free Cash Flow

-$4.87M

-87.7%

Operating Cash Flow

-$4.87M

-87.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.79+3.33%

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.65+0.00%

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.38+1.62%

PMCBPharmaCyte Biotech, Inc.

PMCBPharmaCyte Biotech, Inc.$0.78+1.07%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.15-0.46%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.57+5.40%

PLRZPolyrizon Ltd.

PLRZPolyrizon Ltd.$11.80-10.54%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.70-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

PFEPfizer

PFEPfizer$24.72-0.01%

TAT&T

TAT&T$22.81+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

FFord Motor Company

FFord Motor Company$14.00-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.82-0.12%

Questions About QNRX

What is the current price of Quoin Pharmaceuticals?

Quoin Pharmaceuticals is trading at $3.25 per share.

What is the 52-week range for Quoin Pharmaceuticals?

Over the past 52 weeks, Quoin Pharmaceuticals has traded between $3.25 and $41.80.

How much debt does Quoin Pharmaceuticals have?

As of the most recent reporting period, Quoin Pharmaceuticals reported total debt of $0.00.

How much cash does Quoin Pharmaceuticals have on hand?

Quoin Pharmaceuticals reported $3.12M in cash and cash equivalents in its most recent financial results.

What is Quoin Pharmaceuticals’s dividend yield?

Quoin Pharmaceuticals does not currently have a dividend yield.

Quoin Pharmaceuticals

Quoin Pharmaceuticals Financials at a Glance

QNRX News

Quoin (QNRX) Q2 Loss Beats Estimates

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Quoin Pharmaceuticals

QNRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Quoin Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About QNRX

What is the current price of Quoin Pharmaceuticals?

What is the 52-week range for Quoin Pharmaceuticals?

How much debt does Quoin Pharmaceuticals have?

How much cash does Quoin Pharmaceuticals have on hand?

What is Quoin Pharmaceuticals’s dividend yield?

Premium Investing Services